Europe vs Indonesia: Proportion of the target population who received the final dose of
Europe
40.0%
in 2024
Indonesia
79.0%
in 2024
Europe rank
21st
Indonesia rank
24th
Proportion of the target population who received the final dose of over time
- Europe
- Indonesia
How they compare
Indonesia currently reports 79.0% against 40.0% in Europe, a difference of 39.0%.
That makes Indonesia's figure about 2.0 times Europe's.
The two have swapped places 1 time across 8 shared years of data; in 2017 it was Europe ahead.
Europe ranks 21st and Indonesia ranks 24th of 35 groups.
Europe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Europe | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 34.0% | 2.7% | 31.3% | Europe |
| 2020s | 36.8% | 24.6% | 12.2% | Europe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Europe or Indonesia?
- Indonesia, at 79.0% against 40.0% in Europe as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Europe and Indonesia?
- 39.0%, with Indonesia ahead.
- How many years of comparable data are there for Europe and Indonesia?
- 8 years are reported by both, from 2017 to 2024.
- How do Europe and Indonesia rank globally for proportion of the target population who received the final dose of?
- Europe ranks 21st and Indonesia ranks 24th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.